Bruno Dietrich

658 total citations
14 papers, 121 citations indexed

About

Bruno Dietrich is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Bruno Dietrich has authored 14 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Bruno Dietrich's work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Hormonal and reproductive studies (3 papers). Bruno Dietrich is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Hormonal and reproductive studies (3 papers). Bruno Dietrich collaborates with scholars based in Germany, Italy and Switzerland. Bruno Dietrich's co-authors include Steffen Goletz, Willi Cawello, Detlef Albrecht, Horst Schweer, Hannsjörg W. Seyberth, Kelvin Eckert, Rolf Pokorny, Hans Baumeister, Antje Danielczyk and Walter Fiedler and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Urology.

In The Last Decade

Bruno Dietrich

14 papers receiving 116 citations

Peers

Bruno Dietrich

PMH

MB

EDM

IMMUN

RNMI

Caroline Andy United States

Constantinos Psarros Greece

Brittany Bettendorf United States

R. Rox Anderson United States

Christina Neophytou United Kingdom

Tatiane Sousa e Silva Brazil

Massimo Giusti Italy

Arik Shechter Israel

Maria Arvio Finland

Caroline Andy United States

Bruno Dietrich

16 ×0.5

PMH

31 ×1.1

MB

58 ×2.0

EDM

13 ×0.5

IMMUN

9 ×0.4

RNMI

Citations per year, relative to Bruno Dietrich Bruno Dietrich (= 1×) peers Caroline Andy

Countries citing papers authored by Bruno Dietrich

Since Specialization

Citations

This map shows the geographic impact of Bruno Dietrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Dietrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Dietrich more than expected).

Fields of papers citing papers by Bruno Dietrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Dietrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Dietrich. The network helps show where Bruno Dietrich may publish in the future.

Co-authorship network of co-authors of Bruno Dietrich

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Dietrich. A scholar is included among the top collaborators of Bruno Dietrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Dietrich. Bruno Dietrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Griesinger, Georg, et al.. (2019). Fully human glyco-optimized recombinant FSH (follitropin epsilon) – a randomized, comparator-controlled phase II clinical trial. Reproductive BioMedicine Online. 40(2). 331–341. 11 indexed citations

2.

Fiedler, Walter, Herbert Stoeger, Antonella Perotti, et al.. (2018). Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours. ESMO Open. 3(4). e000381–e000381. 14 indexed citations

3.

Fiedler, Walter, Sara Cresta, Henning Schulze‐Bergkamen, et al.. (2018). Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas. ESMO Open. 3(2). e000303–e000303. 12 indexed citations

4.

Keilholz, Ulrich, Andrzej Kawecki, Andreas Dietz, et al.. (2018). Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study.. Journal of Clinical Oncology. 36(5_suppl). 59–59. 4 indexed citations

5.

Baumeister, Hans, Alfredo Zurlo, Jérôme Fayette, Bruno Dietrich, & Ulrich Keilholz. (2018). CetuGEX and cetuximab in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): PK/PD results from the phase II RESGEX study.. Journal of Clinical Oncology. 36(5_suppl). 61–61. 1 indexed citations

6.

Duijkers, Ingrid, et al.. (2017). A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials. Human Reproduction. 32(8). 1639–1647. 16 indexed citations

7.

Samonigg, Hellmut, Sara De Dosso, Antonella Perotti, et al.. (2014). Glyco-optimized trastuzumab-GEX, a novel anti-HER2 monoclonal antibody with ADCC activity: A phase I clinical study in patients with HER2-positive tumors.. Journal of Clinical Oncology. 32(15_suppl). 2515–2515. 1 indexed citations

8.

Fiedler, Walter, Cristiana Sessa, Luca Gianni, et al.. (2013). First-in-human phase I study of CetuGEX, a novel anti-EGFR monoclonal antibody (mAb) with optimized glycosylation and antibody dependent cellular cytotoxicity.. Journal of Clinical Oncology. 31(15_suppl). 3008–3008. 1 indexed citations

9.

Herrlinger, Klaus, Mircea Diculescu, Klaus Fellermann, et al.. (2011). Efficacy, Safety and Tolerability of Vidofludimus in Patients With Inflammatory Bowel Disease: The ENTRANCE Study. Gastroenterology. 140(5). S–588. 8 indexed citations

10.

Dietrich, Bruno. (1997). Polysomnography in Drug Development. The Journal of Clinical Pharmacology. 37(S1). 70S–78S. 8 indexed citations

11.

Cawello, Willi, et al.. (1997). PHARMACOKINETICS OF PROSTAGLANDIN E1 AND ITS MAIN METABOLITES AFTER INTRACAVERNOUS INJECTION AND SHORT-TERM INFUSION OF PROSTAGLANDIN E1 IN PATIENTS WITH ERECTILE DYSFUNCTION. The Journal of Urology. 1403–1407. 1 indexed citations

12.

Cawello, Willi, et al.. (1997). Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction.. PubMed. 158(4). 1403–7. 19 indexed citations

13.

Cawello, Willi, et al.. (1997). PHARMACOKINETICS OF PROSTAGLANDIN E1 AND ITS MAIN METABOLITES AFTER INTRACAVERNOUS INJECTION AND SHORT-TERM INFUSION OF PROSTAGLANDIN E1 IN PATIENTS WITH ERECTILE DYSFUNCTION. The Journal of Urology. 158(4). 1403–1407. 15 indexed citations

14.

Pokorny, Rolf, et al.. (1995). Memory and Attention Test Performance of Young and Elderly Subjects After Retest Practice. International Psychogeriatrics. 7(3). 377–384. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact